Complexity in the regulation of Dicer expression: Dicer variant proteins are differentially expressed in epithelial and mesenchymal breast cancer cells and decreased during EMT
2011

Dicer Expression in Breast Cancer

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): Hinkal G W, Grelier G, Puisieux A, Moyret-Lalle C

Primary Institution: Centre Léon Bérard

Hypothesis

Is there a competition between different miRNAs in binding their targets in Dicer regulation?

Conclusion

Dicer downregulation is associated with epithelial-mesenchymal transition (EMT) in breast cancer.

Supporting Evidence

  • Dicer expression was significantly decreased in breast cancer cells with mesenchymal phenotypes.
  • Lower Dicer levels were associated with lower metastasis-free survival in breast cancer patients.
  • Different Dicer mRNA variants were identified, correlating with breast cancer staging subtypes.

Takeaway

This study looks at how a protein called Dicer, which helps make small RNA molecules, is affected in breast cancer cells. When Dicer levels go down, it can lead to changes in how the cancer cells behave.

Methodology

Dicer expression was assessed using RT-qPCR and western blotting in breast cancer cell lines and patient cohorts.

Limitations

The physiological relevance of the findings remains to be clarified.

Participant Demographics

Breast cancer cell lines and human cohort data were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606022

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication